Literature DB >> 30620044

A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity.

Jake H McKay1, Elliot L Dimberg2, Alfonso S Lopez Chiriboga3.   

Abstract

OBJECTIVE: To review the available research to describe the clinical characteristics and neoplastic associations of patients with gamma-aminobutyric acid receptor type B (GABAB-R) autoantibodies.
METHODS: Literature was reviewed on PubMed, Mendeley literature search, and the American Academy of Neurology database for articles published from June 2008 to October of 2018 using a variety of key words. These key words include: "gamma-aminobutyric acid seizures," "gamma-aminobutyric acid limbic encephalitis", "GABA(B) receptor antibodies," "autoimmune encephalitis," "autoimmune epilepsy," "GABA(B) encephalitis, " and "GABA paraneoplastic." With the results, the papers were reviewed in a systematic manner.
RESULTS: A total of 10 studies were reviewed. A summary of the demographic, clinical, and serological findings of the cases detailed in the literature are provided. An additional illustrative case is described. In total, 94 patients were reviewed.
CONCLUSIONS: GABAB-R autoimmune disease is characterized by refractory seizures or status epilepticus and frequent association with small cell lung cancer. Additionally, a substantial minority of patients have non-inflammatory CSF.

Entities:  

Keywords:  GABA limbic encephalitis; GABA paraneoplastic; GABA(B) receptor antibodies; GABA-B encephalitis; Gamma-aminobutyric acid seizures; autoimmune encephalitis; autoimmune epilepsy; gamma-aminobutyric acid receptor type B

Mesh:

Substances:

Year:  2019        PMID: 30620044     DOI: 10.5603/PJNNS.a2018.0005

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  8 in total

Review 1.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

2.  Coexistence of Anti-SOX1 and Anti-GABAB Receptor Antibodies with Autoimmune Encephalitis in Small Cell Lung Cancer: A Case Report.

Authors:  Wei Qin; Xiao Wang; Jing Yang; Wenli Hu
Journal:  Clin Interv Aging       Date:  2020-02-07       Impact factor: 4.458

3.  A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors.

Authors:  Xiangchuan Wen; Baojie Wang; Chunjuan Wang; Chenglin Han; Shougang Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-18       Impact factor: 2.570

4.  A Prognostic Analysis of the Outcomes in Patients With Anti-γ-Aminobutyric Acid B Receptor Encephalitis.

Authors:  Weibi Chen; Yunyun Wang; Xiaoyuan Guo; Lehong Gao; Zhaoyang Huang; Yicong Lin; Qin Xue; Gang Liu; Yan Zhang; Yingying Su
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

Review 5.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

6.  Revealing the pharmacological effect and mechanism of darutoside on gouty arthritis by liquid chromatography/mass spectrometry and metabolomics.

Authors:  Jing Wang; Yan-Chun Sun
Journal:  Front Mol Biosci       Date:  2022-08-24

7.  Pulmonary infection and baseline mRS scores predict poor prognosis in anti-GABABR encephalitis.

Authors:  Junqing Ding; Dingkang Xu; Jie Lv; Tianwen Wu; Jinghong Li; Mi Tian; Yajun Lian
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

8.  Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.

Authors:  Yilin Wang; Xin Li; Pingping He; Jiangning Yin; Ruofei Dong; Yu Fu; Hong Zhang
Journal:  CNS Neurosci Ther       Date:  2021-03-08       Impact factor: 5.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.